Citadel Advisors’s T-Rex 2X Inverse MSTR Daily Target ETF MSTZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
– Sell
-13,364
Closed -$179K – 14541
2025
Q4
$229K Sell
13,364
-285,372
-96% -$2.9M ﹤0.01% 10737
2025
Q3
$1.57M Buy
298,736
+111,214
+59% +$499K ﹤0.01% 6568
2025
Q2
$784K Sell
187,522
-124,972
-40% -$784K ﹤0.01% 7610
2025
Q1
$4.38M Buy
+312,494
New +$5.48M ﹤0.01% 4098

Other funds holding MSTZ

Citadel Advisors's MSTZ Position: Q1 2026 in Review

Citadel Advisors sold out of T-Rex 2X Inverse MSTR Daily Target ETF (MSTZ) in Q1 2026, closing a stake of 13,364 shares — an estimated $179K sold.

Citadel Advisors first reported a position in MSTZ in Q1 2025 and held it in 4 quarters. The position peaked at $4.38M in Q1 2025. 16 funds tracked by Wall St. Rank hold MSTZ as of Q1 2026.

  • Citadel Advisors reported no remaining T-Rex 2X Inverse MSTR Daily Target ETF position as of Q1 2026 after selling out during the quarter.
  • Citadel Advisors sold 13,364 T-Rex 2X Inverse MSTR Daily Target ETF shares in Q1 2026, an estimated $179K.
  • Citadel Advisors first reported a position in T-Rex 2X Inverse MSTR Daily Target ETF in Q1 2025 and held it in 4 quarters.
  • Citadel Advisors's T-Rex 2X Inverse MSTR Daily Target ETF position peaked at $4.38M in Q1 2025.
  • 16 funds tracked by Wall St. Rank held T-Rex 2X Inverse MSTR Daily Target ETF as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.